Data gathered: November 19
AI Stock Analysis - Clover Health (CLOV)
Analysis generated September 13, 2024. Powered by Chat GPT.
Clover Health is a next-generation Medicare Advantage insurer focused on utilizing data and technology to improve health outcomes for its members. The company aims to empower patients through its innovative approach which integrates data analytics and personalized care management. Clover's primary market is in the United States, where it competes with established Medicare Advantage providers. The company went public via a SPAC (Special Purpose Acquisition Company) merger in 2021, attracting substantial investor interest due to its disruptive business model and growth potential.
Stock Alerts - Clover Health (CLOV)
 |
Clover Health | November 18 Price is up by 5.1% in the last 24h. |
|
Clover Health | November 13 Web Traffic is up by 107% over the last month. |
|
Clover Health | November 8 Price is down by -6.5% in the last 24h. |
|
Clover Health | November 7 Price is down by -10.3% in the last 24h. |
Alternative Data for Clover Health
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 21 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 301,000 | Sign up | Sign up | Sign up |
| Employee Rating | 68 | Sign up | Sign up | Sign up |
| Google Trends | 50 | Sign up | Sign up | Sign up |
| Patents | 1 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2,549 | Sign up | Sign up | Sign up |
| Facebook Followers | 4,002 | Sign up | Sign up | Sign up |
| Reddit Mentions | 5 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 70 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 85,631 | Sign up | Sign up | Sign up |
| Twitter Followers | 357 | Sign up | Sign up | Sign up |
| Twitter Mentions | 120 | Sign up | Sign up | Sign up |
| News Mentions | 2 | Sign up | Sign up | Sign up |
| Customer reviews | 48 | Sign up | Sign up | Sign up |
| Lobbying Cost | $13,000 | Sign up | Sign up | Sign up |
| Business Outlook | 52 | Sign up | Sign up | Sign up |
| Linkedin Employees | 589 | Sign up | Sign up | Sign up |
| NPS | 3 | Sign up | Sign up | Sign up |
About Clover Health
Clover Health is a healthcare technology company that offers Medicare Advantage plans with a deeply-rooted mission of helping its members live their healthiest lives. Clover Health uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients.
| Price | $3.28 |
| Target Price | Sign up |
| Volume | 5,160,000 |
| Market Cap | $1.52B |
| Year Range | $0.62 - $4.35 |
| Dividend Yield | 0% |
| Analyst Rating | 33% buy |
| Industry | Insurance |
In the news
 |
Sigma Planning Corp Invests $29,000 in Clover Health Investments, Corp. (NASDAQ:CLOV)November 18 - ETF Daily News |
|
Clover Health Investments, Corp. (NASDAQ:CLOV) Short Interest UpdateNovember 17 - ETF Daily News |
 |
Clover Health: Buy The Dip, Reap The RewardsNovember 17 - SeekingAlpha |
|
Research Analysts Set Expectations for CLOV FY2024 EarningsNovember 10 - ETF Daily News |
|
Leerink Partnrs Analysts Boost Earnings Estimates for CLOVNovember 9 - ETF Daily News |
|
Stock Traders Buy Large Volume of Call Options on Clover Health Investments (NASDAQ:CLOV)November 8 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 331M | 250M | 81M | -9.2M | -8.4M | -0.020 |
| Q2 '24 | 356M | 248M | 108M | 7.4M | 7.5M | 0.010 |
| Q1 '24 | 347M | 265M | 82M | -19M | -22M | -0.040 |
| Q4 '23 | 510M | 448M | 62M | -70M | -65M | -0.140 |
| Q3 '23 | 306M | 419M | 70M | -41M | -41M | -0.090 |
Insider Transactions View All
| Garipalli Vivek filed to buy 1,409,267 shares at $1.9. August 13 '24 |
| Garipalli Vivek filed to buy 877,567 shares at $1.1. June 20 '24 |
| Loengard Anna U filed to buy 10,000 shares at $0.9. May 20 '24 |
| Loengard Anna U filed to buy 15,110 shares at $0.9. May 20 '24 |
| Loengard Anna U filed to buy 15,600 shares at $1. May 20 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
AllstateALL |
$196.6 1.7% | 64 |
 |
ProgressivePGR |
$254.51 0.8% | 61 |
 |
MetLifeMET |
$82.63 0.9% | 65 |
 |
AflacAFL |
$111.13 0.8% | 53 |
 |
LemonadeLMND |
$40.14 17% | 49 |
Read more about Clover Health (CLOV) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Clover Health?
The Market Cap of Clover Health is $1.52B.
What is the current stock price of Clover Health?
Currently, the price of one share of Clover Health stock is $3.28.
How can I analyze the CLOV stock price chart for investment decisions?
The CLOV stock price chart above provides a comprehensive visual representation of Clover Health's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Clover Health shares. Our platform offers an up-to-date CLOV stock price chart, along with technical data analysis and alternative data insights.
Does CLOV offer dividends to its shareholders?
As of our latest update, Clover Health (CLOV) does not offer dividends to its shareholders. Investors interested in Clover Health should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Clover Health?
Some of the similar stocks of Clover Health are Allstate, Progressive, MetLife, Aflac, and Lemonade.
.